Purchase this article with an account.
Michael Conwell, Sonia DaSilva-Arnold, Na Luo, Wei Li, Jeffery Travers, Yang Sun; Model of allergic keratoconjunctivitis - Stat6 signaling in chronic inflammation. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2081.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
The purpose of this study is to characterize the corneal inflammatory lesions found in the Stat6VT mouse as a model for atopic dermatitis. We hypothesize that the constitutive activation of Stat6 results in corneal neovascularization and pannus formation.
SKH1-HrHr wild-type mice and mice which express an integrally active Stat6 (Stat6VT), V547A/T548A, (N=20, 24 respectively) where examined for the development of keratoconjunctivitis. Corneas were removed and examined by H&E and PAS staining. Immunoblot analysis was performed with Interleukin-4, Interferon gamma, and CD3. Steroid treatment with clobetasol was performed on affected lesions.
Compared to wild-type, Stat6VT transgenic mice exhibited increased frequency of corneal neovascularization (N=24, P<0.05). The Stat6VT transgenic mice demonstrated corneal infiltrate as well as neovascularization (N=5, P<0.05). Real-time PCR analyses performed on the mRNA from both the wild type and Stat6VT mice yielded elevated levels of Th2 cytokines isolated from the Stat6VT mice (N=5,5 respectively P<0.05). We showed that clobetasol treatment slowed the development of periocular and corneal lesions.
Stat6 signaling may play a role in the pathogenesis of chronic ocular inflammation. IL-4 may mediate corneal inflammation in allergic keratoconjunctivitis.
This PDF is available to Subscribers Only